Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
Financial Results:
Dishman Carbogen Amcis Ltd reported Revenues for Q2FY24 of ₹587.00 Crores down from ₹614.00 Crore year on year, a fall of 4.4%.
Total Expenses for Q2FY24 of ₹628.00 Crores down from ₹635.00 Crores year on year, a fall of 1.1%.
Consolidated Net Profit of -₹41.00 Crores from -₹10.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹2.61, from -₹0.64 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.